Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-08-09
2011-08-09
Saoud, Christine J (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100, C435S007200, C530S350000, C530S351000
Reexamination Certificate
active
07993845
ABSTRACT:
The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
REFERENCES:
patent: 6326472 (2001-12-01), Timans et al.
patent: 0464533 (1991-06-01), None
patent: 99/19480 (1999-04-01), None
Adachi et al., “Targeted disruption of the MyD88 gene results in loss of IL-1 and IL-18-mediated function,” Immunity, 9:143-150, 1998.
Bacher et al., “The NF-KB pathway as a potential target for autoimmune disease therapy,” Curr. Pharm. Design, 10:2827-2837, 2004.
Bonnert, T. P. et al., “The cloning and characterization of human MyD88: a member of an IL-1 receptor related family,” FEBS Letters, 402:81-84, 1997.
Born T. L. et al., “Cloning of a novel receptor subunit, AcPL, required for Interleukin-18 signaling,” J. Biol. Chem., 273 (45) 29445-29450, 1998.
Debets et al., “IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL antibody, a potent antagonist of IL-18,” J. Immunol., 165:4950-4956, 2000.
Gillespie et al., “Interleukin-18 perspectives on the newest interleukin,” Cytokine and Growth Factor Reviews, 9 (2):109-116, 1998.
Greenfeder S. A. et al., “Molecular cloning and characterization of a second subunit of the Interleukin 1 receptor complex,” J. Biol. Chem., 270(23):13757-13765, 1995.
Lejeune et al., The interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line, J. Biol. Chem., 37:33676-33682, 2002.
Li et al., IL-1-induced NFKB and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK), Proc. Natl. Acad. Sci. USA, 98(8):4461-4465, 2001.
Lovenberg, T. W. et al., “Cloning of a cDNA encdoding a novel interleukin-1 receptor related protein (IL1R-rp2),” J. Neuroimmunol., 70:113-122, 1996.
Parnet P. et al., “IL-1Rrp is a novel receptor-like molecule similar to the type I Interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP,” J. Biol. Chem., 271(8):3967-3970, 1996.
Rock, F. L. et al., “A family of human receptors structurally related toDrosophilaToll,” Proc. Natl. Acad. Sci. USA, 95:588-593, 1998.
Thomassen, E. et al., “Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1,” J. Interferon Cytokine Res., 18:1077-1088, 1998.
Torigoe K. et al., “Purification and characterization of the human Interleukin-18 receptor,” J. Biol. Chem., 272 (41):25737-25742, 1997.
Wullaert et al., “Mechanisms of crosstalk between TNF-induced NF-KB and JNK activation in hepatocytes,” Biochem. Pharm., 72:1090-1101, 2006.
Wells J.A., “Additivity of mutational effects in proteins,” Biochemistry 29(37):8509-8517, 1990.
Ngo et al., “Computational complexity, protein structure prediction, and the Levinthal paradox,” In Merz and LeGrand (Eds.), The Protein Folding Problem and Tertiary Structure Prediction, Birkhauser:Boston, pp. 491-495, 1994.
Born Teresa L.
Sims John E.
Immunex Corporation
Lockard Jon M
Saoud Christine J
Wrona Thomas J.
LandOfFree
ACPL-related assays does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with ACPL-related assays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ACPL-related assays will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2789835